Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Anaptysbio (ANAB) Leases (2019 - 2025)

Anaptysbio's Leases history spans 7 years, with the latest figure at $12.5 million for Q4 2025.

  • For Q4 2025, Leases fell 12.96% year-over-year to $12.5 million; the TTM value through Dec 2025 reached $12.5 million, down 12.96%, while the annual FY2025 figure was $12.5 million, 12.96% down from the prior year.
  • Leases reached $12.5 million in Q4 2025 per ANAB's latest filing, down from $13.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $20.3 million in Q2 2021 to a low of $218000.0 in Q1 2021.
  • Average Leases over 5 years is $15.7 million, with a median of $16.4 million recorded in 2023.
  • Peak YoY movement for Leases: tumbled 82.03% in 2021, then surged 8683.03% in 2022.
  • A 5-year view of Leases shows it stood at $19.6 million in 2021, then decreased by 8.49% to $17.9 million in 2022, then dropped by 9.63% to $16.2 million in 2023, then decreased by 11.07% to $14.4 million in 2024, then fell by 12.96% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Leases are $12.5 million (Q4 2025), $13.0 million (Q3 2025), and $13.5 million (Q2 2025).